Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-067122
Filing Date
2025-03-28
Accepted
2025-03-28 16:22:43
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 d847359ds3.htm S-3 403507
2 EX-1.2 d847359dex12.htm EX-1.2 183466
3 EX-4.2 d847359dex42.htm EX-4.2 277235
4 EX-4.3 d847359dex43.htm EX-4.3 276812
5 EX-5.1 d847359dex51.htm EX-5.1 13570
6 EX-5.2 d847359dex52.htm EX-5.2 7352
7 EX-23.1 d847359dex231.htm EX-23.1 1649
8 EX-FILING FEES d847359dexfilingfees.htm EX-FILING FEES 52570
9 GRAPHIC g847359dsp4.jpg GRAPHIC 4166
10 GRAPHIC g847359g0326180135947.jpg GRAPHIC 2755
11 GRAPHIC g847359g09p96.jpg GRAPHIC 50767
12 GRAPHIC g847359g67o79.jpg GRAPHIC 50066
  Complete submission text file 0001193125-25-067122.txt   1366245
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-286222 | Film No.: 25786651
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)